Cargando…
Effect of farnesyltransferase inhibitors on SARS-CoV-2
OBJECTIVES: The emergence of SARS-CoV-2 in 2019 led to a severe pandemic situation. Treatment options are limited, and the efficacy of vaccines decreases due to mutations in SARS-CoV-2 strains. Therefore, new treatment options are urgently needed, and computational compound screenings are used to pr...
Autores principales: | Weber, Lea, Mautner, Lena, Hoyos, Mona, Ehrhardt, Anja, Baiker, Armin, Bachmann, Hagen Sjard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711904/ https://www.ncbi.nlm.nih.gov/pubmed/36462736 http://dx.doi.org/10.1016/j.jgar.2022.11.011 |
Ejemplares similares
-
SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020) -
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020) -
In vitro evaluation of the virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2
por: Dessilly, Géraldine, et al.
Publicado: (2022) -
Thrombose und COVID-19
por: Tzaneva, Stanislava
Publicado: (2021) -
What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web survey helps us to understand where the doubts lie
por: Colaneri, Marta, et al.
Publicado: (2021)